跳至主要内容
临床试验/IRCT2014030611375N2
IRCT2014030611375N2已完成未知

Effects of walnut oil on lipid profiles in hyperlipidemic type 2 diabetic patients

Shiraz University of Midical Sciences0 个研究点目标入组 90 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
90

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20 years 至 75 years(—)
性别
All

入选标准

  • Inclusion Criteria: Patients with diagnosed type2 diabetes for at leat 2 years and also with either plasma TG level more 150 mg/dL or total cholestrol level more 200 mg/dL or LDL between 130-200 or HDL less 50 in female and less 40 in male; Patients who received maximum 2 oral diabetes medications.

排除标准

  • Patients who have a history of chronic or metabolic diseases, or regularly use medication (Fibrate and HMG-COA Reductase inhibitor) or supplements known to affect blood lipids; Patients who have to receive antihyperlipidemic agents for example CAD patients; Patients who were currently received insulin therapy.

研究者

发起方
Shiraz University of Midical Sciences

相似试验